Time to read: 10 minutes
Updated Mon, Oct 05, 2009 @ 07:48 AM
Originally Published Mon, Oct 05, 2009 @ 07:48 AM
Blog / FDA Awards Biosearch Technologies $3.4 MM Contract
Updated Mon, Oct 05, 2009 @ 07:48 AM
Originally Published Mon, Oct 05, 2009 @ 07:48 AM
The FDA has awarded Biosearch Technologies a five year contract for the development of multiplexed, fluorescent bead-based assays to determine bioterror and food safety pathogens. The assay will be conducted on a Luminex® xMap® platform. Throughout the contract, Biosearch will collaborate with scientists at Lawrence Livermore National Laboratories (LLNL) and the Luminex Corporation to develop assays for agents listed by the CDC and USDA. Initial target analytes include Bacillus anthracis, the causative agent of anthrax; Yersinia pestis, the causative agent of the plague; and Francisella tularensis, the causative agent of tularemia.
To read the entire story, read the full press release.
LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.